ClinicalTrials.Veeva

Menu

Prospective Study on Prognosis of Cardiac Resynchronized Therapy (CRT), Implantable Cardioverter Defibrillator (ICD) Implantation in Patients With Congestive Heart Failure (CHF)

Yonsei University logo

Yonsei University

Status

Unknown

Conditions

Congestive Heart Failure

Treatments

Procedure: ICD/CRT

Study type

Observational

Funder types

Other

Identifiers

NCT02139449
4-2014-0098

Details and patient eligibility

About

CRT and ICD has known as decreasing cardiac mortality in patient with heart failure. Especially, it has reported that CRT improved cardiac systolic function, quality of life of patients with heart failure. However, CRT and primary ICD was not generalized in Korea. So the investigators will register patients who implant CRT or ICD (primary), and follow them up. During scheduled follow up, all patients will perform echocardiography, 6 minute walking test, EKG, Holter monitoring and questionnaire on QOL.

Enrollment

1,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age >=18
  2. LV ejection fraction <40% or Clinical HF Symptom with (LV ejection fraction >40%)
  3. medication for at least 3month

Exclusion criteria

  1. patient who refuse to enroll the study

Trial design

1,000 participants in 1 patient group

ICD/CRT registry
Description:
ICD / CRTregistry in Severance or Ewha Womans University Medical Center
Treatment:
Procedure: ICD/CRT

Trial contacts and locations

1

Loading...

Central trial contact

Boyoung Joung, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems